While Asenathi Ntlabakanye doping hearing decision is only expected at the end of May, the powerhouse prop will be vital in the hunt for a historic quarter-final spot against Leinster and Munster. Photo: Backpagepix
Image: Backpagepix
Prop Asenathi Ntlabakanye will be free to play for the Lions until possibly the end of May, before the outcome of his hearing for an alleged doping violation is finalised.
Closing arguments in the case against the Springbok tighthead were only heard two weeks ago, the South African Institute for Drug-Free Sport (SAIDS) confirmed to Independent Media on Tuesday. SAIDS CEO Khalid Galant said the panel is currently deliberating the case.
“I expect a decision before the end of May,” Galant said.
Earlier indications, as reported by Independent Media, suggested that Ntlabakanye’s fate would be known in April, but Galant confirmed it will now only be before the end of this month.
That means Ntlabakanye will in all likelihood be available for the Lions’ final two league matches — against Leinster and Munster — in Ireland. However, should the verdict be delivered at the end of the month, the Lions stalwart could potentially miss the URC quarter-finals if he is found guilty of the doping violation.
It would be a significant blow for the Lions as they aim to progress as far as possible in the tournament. Ntlabakanye tested positive for the non-performance-enhancing banned substance Anastrozole in August last year, a drug primarily used in the treatment of breast cancer. The issue with this substance is that it blocks oestrogen and can counteract the side effects of anabolic steroids.
However, with the scrummager set to feature in the final two matches, the Lions should be at full strength to take on Leinster and Munster — both renowned for their scrummaging power — at the set piece. Ntlabakanye’s carries in attack, along with his solid defence, could also help blunt the physical onslaught of the Irish sides.
Just one away victory will be enough to secure a first-ever quarter-final berth for the visitors.